LYCA Award Disclosure
Staben Steven · SEC Form 4 · Filed Oct 26, 2026
Award
Calculated transaction value
$0
Staben Steven Chief Scientific Officer
LYCA
Transaction date
Aug 11, 2026
Public filing date
Oct 26, 2026
Filing lag
Filed 76 days later
LYCA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 110,896 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002159565-26-000005
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lycia Therapeutics, Inc. LYCA Current | Award | Aug 11, 2026 | $0 |